⏳
Showing Q4 2024 data
Alerce Investment Management, L.P.'s Q4 2025 filing not yet available. Expected by Feb 14, 2026.
Alerce Investment Management, L.P.
•CIK: 1844002•Filing: Q4 2024
Alerce Investment Management, L.P. manages $57M across a concentrated portfolio of five positions. The fund exhibits a significant overweighting in ANNX, representing $38.0M of its total assets. Further notable allocations include AKBA at $10.9M, VRNA at $4.1M, and AMWL at $3.8M. This structure suggests a high-conviction, sector-specific investment approach.
Total AUM
$56.8M
QoQ Performance
-8.9%
Positions
5
Top 10 Concentration
100.0%
Latest Filing
Q4 2024
Top Holdings Allocation
ANNX
AKBA
VRNA
AMWL
ANNX66.9%
AKBA19.2%
VRNA7.2%
AMWL6.7%
WHWK0.0%
📈 Biggest Buys
No new positions or increases this quarter
📉 Biggest Sells
VRNA
VERONA PHARMA PLC
-57.3%
7.2% of portfolio
Sector Breakdown
Other100.0%
Changes from Q3 2024
↓1 decreased
Historical Filings
Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023